Sponsor:
Eclipse Life Sciences, Inc.
Code:
NCT06536491
Conditions
Diabetic Macular Edema
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
EC-104 high dose
EC-104 low dose
Dexamethasone intravitreal implant
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-27. This information was provided to ClinicalTrials.gov by Eclipse Life Sciences, Inc. on 2025-01-22.